Minneapolis Heart Institute Foundation implants its first world's smallest cardiac pacemaker

Minneapolis Heart Institute Foundation implants its 1st world's smallest cardiac pacemaker
"This miniaturized technology is designed to provide patients with the advanced pacing technology of traditional pacemakers via a minimally invasive approach," said MHIF researcher Dr. Charles Gornick, who implanted the pacemaker. "We are proud that MHIF was selected among an elite group of institutions to take part in this clinical trial. If positive, the results of the trial could potentially benefit many people globally who receive pacemakers each year." Credit: AllinaHealth, Medtronic

The Minneapolis Heart Institute Foundation (MHIF) announced today the first implant of the world's smallest pacemaker at the Minneapolis Heart Institute. The device was implanted as part of a global clinical trial and the procedure was the first of its kind in the Midwest.

One-tenth the size of a conventional , and comparable in size to a large vitamin, the Medtronic Micra Transcatheter Pacing System is delivered directly into the through a catheter inserted in the femoral vein. Once positioned, the pacemaker is securely attached to the heart wall and can be repositioned or retrieved if needed. The miniature device does not require the use of wires, known as "leads," to connect to the heart. Attached to the heart via small tines, the pacemaker delivers electrical impulses that pace the heart through an electrode at the end of the device.

"This miniaturized technology is designed to provide patients with the advanced pacing technology of traditional pacemakers via a minimally invasive approach," said MHIF researcher Dr. Charles Gornick, who implanted the pacemaker. "We are proud that MHIF was selected among an elite group of institutions to take part in this clinical trial. If positive, the results of the trial could potentially benefit many people globally who receive pacemakers each year." In contrast to current pacemaker implant procedures, the miniature pacemaker does not require a surgical incision in the chest and the creation of a "pocket" under the skin. This eliminates a potential source of complications, and any visible sign of the device.

"This miniaturized technology is designed to provide patients with the advanced pacing technology of traditional pacemakers via a minimally invasive approach," said MHIF researcher Dr. Charles Gornick, who implanted the pacemaker. "We are proud that MHIF was selected among an elite group of institutions to take part in this clinical trial. If positive, the results of the trial could potentially benefit many people globally who receive pacemakers each year." Credit: Gloria O'Connell, Allina Health


Provided by Minneapolis Heart Institute Foundation

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Pacemaker for slow heart rhythm restores life expectancy

Sep 02, 2013

Pacemakers implanted for slow heart rhythm restore life expectancy to normal levels, reveals research presented at ESC Congress 2013 today by Dr Erik O. Udo from the Netherlands. The findings provide a new reference point ...

Wireless pacemaker shows promise in early study

May 09, 2013

(HealthDay)—Scientists report positive results in early testing of a wireless pacemaker that's placed in the heart instead of being connected to it via wires from the upper chest.

Recommended for you

Results of RIBS IV trial reported

13 hours ago

A new clinical trial comparing the use of everolimus-eluting stents (EES) and drug-eluting balloons (DEB) in treating in-stent restenosis (ISR) from drug-eluting stents found that EES provided superior late angiographic results ...

Results of DKCRUSH-VI trial reported

13 hours ago

A new study found that fractional flow reserve (FFR)-guided provisional side branch (SB) stenting of true coronary bifurcation lesions yields similar outcomes to the current standard of care. The DKCRUSH-VI clinical trial ...

Results of IVUS-CTO trial reported at TCT 2014

13 hours ago

A new study found that intravascular ultrasound (IVUS) -guided intervention in patients with chronic total occlusion (CTO) could improve outcomes compared to a conventional angiography-guided approach during percutaneous ...

Results of OCT STEMI trial reported at TCT 2014

13 hours ago

The first randomized trial to examine serial optical coherence tomography (OCT) in primary percutaneous coronary intervention (PCI) was reported at the 26th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific ...

INR variability predicts warfarin adverse effects

19 hours ago

(HealthDay)—Unstable anticoagulation predicts warfarin adverse effects regardless of time in therapeutic range, according to a study published online Sept. 2 in Circulation: Cardiovascular Quality and Ou ...

User comments